Go Pro
CVE:QPT

Quest PharmaTech (QPT) Stock Price, News & Analysis

Quest PharmaTech logo
C$0.02 0.00 (0.00%)
As of 08/27/2026

About Quest PharmaTech Stock (CVE:QPT)

Advanced

Key Stats

Today's Range
C$0.02
C$0.02
50-Day Range
C$0.02
C$0.03
52-Week Range
C$0.02
C$0.05
Volume
10,000 shs
Average Volume
55,263 shs
Market Capitalization
C$3.38 million
P/E Ratio
0.67
Dividend Yield
6.15%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Receive QPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QPT Stock News Headlines

Quest PharmaTech Inc.
QPT Share News Today
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the largest mineral reserve in the country - enough gold for a new Fort Knox, enough copper to rebuild the U.S. electric grid 25 times over. The Trump administration has previously staked positions in MP Materials, Lithium America, Trilogy Metals, and USA Rare Earth - each time shares moved higher. A landmark policy decision expected before November 3 could reprice this stock from $2 to $20 or more within a year.tc pixel
Quest PharmaTech Inc. (QPT.V) - Yahoo Finance
Quest PharmaTech Inc. (QPTFF) - Yahoo Finance
See More Headlines

QPT Stock Analysis - Frequently Asked Questions

Quest PharmaTech's stock was trading at C$0.04 at the beginning of 2026. Since then, QPT stock has decreased by 42.9% and is now trading at C$0.02.

Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athersys (ATHX) and Antibe Therapeutics (ATE).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
CVE:QPT
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.03
Trailing P/E Ratio
0.67
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.88 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-6.28%
Return on Assets
-1.07%

Debt

Debt-to-Equity Ratio
4.35
Current Ratio
0.40
Quick Ratio
0.52

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
20.00
Book Value
C$0.14 per share
Price / Book
0.14

Miscellaneous

Outstanding Shares
169,129,000
Free Float
N/A
Market Cap
C$3.38 million
Optionable
Not Optionable
Beta
-0.07
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (CVE:QPT) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners